About Dayna McGill, MD

Dayna McGill, MD, is a Pediatric Endocrinologist at Mass General Hospital for Children, as well as an Instructor of Pediatrics at Harvard Medical School. Dr. McGill is the Clinical Director for the Division of Pediatric Endocrinology and also the Associate Program Director for the Mass General Hospital Pediatric Endocrine Fellowship Program.

Dr. McGill received her medical degree from New York Medical College, followed by residency training in general pediatrics at the Children’s Hospital of Philadelphia (CHOP) and sub-specialty fellowship training in pediatric endocrinology at the Massachusetts General Hospital and Joslin Diabetes Center. 

Dr. McGill sees children, teens, and young adults with all endocrine concerns. Her practice locations include Boston, Foxborough (Patriot Place) and Cape Cod. Her goal is work with each patient/ family to determine together how to optimize treatment of the child’s endocrine problem in the context of everyday life, family priorities, and technology preferences.

Dr. McGill’s research focuses on the design, implementation, and evaluation of interventions to improve health care delivery and outcomes for young persons with type 1 diabetes (T1D). She has presented her work at national research meetings for the American Diabetes Association (ADA) and the Pediatric Endocrine Society (PES).

Outside of work, she enjoys spending time with her husband and two young children – they can often be found hiking, traveling, or at the beach.

Clinical Interests:



Mass General for Children: Pediatric Endocrine Program and Diabetes Center
55 Fruit St.
Boston, MA 02114
Phone: 617-726-2909

Medical Education

  • MD, New York Medical College
  • Residency, Children's Hospital of Philadelphia
  • Fellowship, Massachusetts General Hospital

American Board Certifications

  • Pediatric Endocrinology, American Board of Pediatrics
  • Pediatrics, American Board of Pediatrics

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


  • McGill DE, Volkening LK, Pober DM, et al. Depressive Symptoms at Critical Times in Youth with Type 1 Diabetes. J Adol Health. 2018;62(2):219-225.

    McGill DE, Volkening LK, Butler DA, et al. Baseline Psychosocial Characteristics Predict Frequency of Continuous Glucose Monitoring in Youth with T1D. DTT. 2018;20(6):434-439.

    McGill DE, Volkening LK, Butler DA, et al. Text Message Responsiveness to Blood Glucose Monitoring Reminders is Associated With HbA1c Benefit in Teenagers with T1D. Diabetic Medicine. 2019;36(5):600-605.

    McGill DE, Laffel LM, Volkening LK, et al. Text Message Intervention for Teens with Type 1 Diabetes Preserves HbA1c: Results of a RCT. DTT. 2020;22(5):374-382.


    McGill DE and Levitsky LL. Management of Hypoglycemia in Children and Adolescents with Type 1 Diabetes Mellitus. Current Diabetes Reports. 2016; 16(9): 88.

    Snelgrove RK, McGill DE, and Laffel LM. Adolescence and Emerging Adulthood: Diabetes in Transition, In: Holt RIG, Cockram C, Flyvbjerg A, Goldstein BJ, eds. Textbook of Diabetes, 5th Ed. Wiley-Blackwell; 2017.

    Commissariat, PV, McGill DE, and Laffel LM. Neuroendocrine and Biobehavioral Influences on Diabetes in Youth, In: Delamater AM and Marrero DG, eds. Behavioral Diabetes; Springer; 2020.

    Atkinson, MA, McGill DE, Dassau, E, and Laffel LM. Type 1 Diabetes Mellitus, In: Melmed S, ed. Williams Textbook of Endocrinology, 14th Ed.; Elsevier; 2020.

    McGill DE. Bone Age, In: Stanley TL and Misra M, eds. Endocrine Conditions in Pediatrics: A Practical Guide; Springer; 2020.

Reviews: Comments and Ratings